rate than does the hydrolysis of the protein. In their experiments they found that when 50 per cent of the protein had been hydrolysed, over 90 per cent of the potency had been destroyed, and concluded that pepsin does not break down crystalline insulin into a simpler, physiologically active substance. More recently, this work has been confirmed by Freudenberg et al. (9) .
The primary object of the present research has been to study the synthetic action of pepsin in peptic digests of insulin. However, since only small quantities of insulin were available, it was considered advisable to investigate the possibility of repeating the experiments of Wasteneys and Borsook with egg albumin, using quantities of the order of 1 gm. Moreover, it was essential to eliminate any procedure used in their experiments which would inactivate insulin, such as heating at 100°C. Since the synthetic action of crystalline pepsin on the products of peptic hydrolysis of egg albumin has not been reported previously, we are recording our findings in the present paper.
EXPERIMENTAL
In general, the procedure used for the hydrolysis and the subsequent synthesis of the protein has been that described by Wasteneys and Borsook. The digestion mixture, consisting of insulin or albumin, in approximately 3 per cent solution together with the pepsin, was adjusted to pH 1.7 with hydrochloric acid. This was incubated at 37°C. for a period varying from 2 hours to 4 days, depending upon the particular experiment. Samples were then removed to determine the extent of hydrolysis, and in the case of insulin, for biological assay. For these tests, it has been our practice to remove five 0.1 cc. samples and dilute them in the following manner. The first sample was diluted with cold isotonic saline, pH 2.5, and the second with cold isotonic saline, pH 8. In order to destroy the enzyme, the third and fourth samples were added to hot (80°C.) acidic and alkaline saline respectively, and after remaining at this temperature for 5 minutes, were cooled to 37°C, The fifth sample was added to 5 cc. of a saturated solution of benzoic acid in ethyl alcohol. About 10 minutes after the addition of this sample, the alcohol was evaporated by heating to 90°C. for about 30 minutes. The insulin was extracted from the residue by shaking with acid water and ether, It has been shown that this procedure will remove insulin from a physiologically inactive insulin-trypsin complex (10) . Immediately after the preparation of each sample, it was assayed biologically, using mice (11) . The dilutions used were calculated on the supposition that 98 per cent of the potency had been destroyed during hydrolysis. The remainder of the digest was adjusted to pH 4.0 with normal sodium hydroxide and concentrated either by distillation under reduced pressure or by complete removal of the water by sublimation in vacuo over concentrated sulfuric acid. When the latter method was used, the solutions were first frozen by means of solid carbon dioxide. The flask used in the concentration of the digest and the subsequent synthesis was a 200 cc. distilling flask with a small pointed tube graduated at 0.6, 1.25, and 2.5 cc. sealed to the bottom. When the solutions were concentrated by distillation, air was admitted slowly by means of a capillary tube reaching to the bottom of the small tube. This was of assistance in preventing bumping. After concentration, an aqueous solution of pepsin was added and then water to make a final volume of 0.6, 1.25, or 2.5 ec. depending upon the amount of protein used for the experiment. This produced a thick suspension. After the addition of 3 small drops of chloroform as a preservative, the mixture was incubated at 37°C. for about 4 days. At the end of this time, water was added to make the volume the same as it had been before the solution was adjusted to pH 4.0. Most of the suspended material remained undissolved (12) . (However, if a sample was centrifuged, the addition of 10 per cent trichloracetic acid to the clear supernatant to make a final concentration of 3.3 per cent produced a distinct precipitate.) Immediately after dilution, samples were removed from the mixture for the estimation of the total and the non-protein nitrogen, and, in the case of insulin experiments, for five potency tests by the methods already described.
In this research, all determinations of pH were made colorimetrically. It was necessary to use this method since the volume of the digest during synthesis was small. The acidity was always checked immediately before incubation.
The criterion for the synthesis of plastein has been a decrease in the non-protein nitrogen during incubation at pH 4.0. In the samples which were removed to determine the non-protein nitrogen, the protein was precipitated by the addition of sufficient 10 per cent trichloracetic acid to make a final concentration of 3.3 per cent. Wasteneys and Borsook used a final concentration of 2.0 per cent trichloracetic acid to precipitate the protein, but it was found, both in the present research and in previous work (8) , that this concentration does not ensure complete precipitation of insulin. Consequently, a final concentration of 3.3 per cent trichloracetic acid has been used in all our experiments. After standing for 1 hour at room temperature, the mixture was centrifuged and the non-protein nitrogen determined in duplicate by the micro Kjeldahl method of Pregl. In the tables the figures listed are for the nitrogen from albumin or from insulin only. The pepsin nitrogen has been subtracted from the non-protein nitrogen fraction, since pepsin is not precipitated under these conditions. In some experiments, the precipitated protein was washed with 3.3 per cent trichloracetic acid, dissolved in normal sodium hydroxide, and the nitrogen estimated. In all experiments, a record of the samples removed for nitrogen determinations and for biological assay was kept. The nitrogen contained in these samples has been calculated, and the proper corrections made in the tables. In accordance with the method adopted by Wasteneys and Borsook, the per cent synthesis has been expressed as the ratio of the plastein nitrogen to the total nitrogen after synthesis. In a later section of the present paper, it is shown that the value of the non-protein nitrogen after hydrolysis or synthesis can be determined more accurately than the protein or the total nitrogen. Therefore, the values for the plastein nitrogen have been obtained by subtracting the non-protein nitrogen after incubation at pH 4.0 from the non-protein nitrogen after hydrolysis.
The crystalline pepsin prepared in these Laboratories was obtained from Parke, Davis and Company pepsin (1:10,000) by the method of Northrop (13) . Although the product thus formed was crystalline in nature and was much more active than the amorphous pepsin, yet the crystals, when viewed under the microscope, appeared to be mostly spherical in shape and lacked a definite crystalline form. In view of this, it was not certain that the pepsin had been obtained in the most highly purified form. However, on comparing our material with a sample of crystalline pepsin kindly supplied us by Dr. Northrop, it was found that the activity of the two samples was the same. This was done by determining the rate of formation of non-protein nitrogen in a casein solution after digestion with pepsin for 1 hour at 37°C. (14) . Using the edestin method of Fuld, the samples of crystalline pepsin were found to possess the same degree of activity, though much higher results were obtained by this method than by the previous one.
In the albumin experiments, Merck's egg albumin was used. The amorphous insulin was prepared in these Laboratories by a method already described (15) , and contained 15 units per mg. The crystalline insulin was prepared from this material. It was recrystallised several times from a phosphate buffer solution and had a potency of 25 units per mg.
The exact experimental data for the individual experiments are given below. The object of the first experiment was to determine the possibility of demonstrating synthesis of plastein when a small quantity of albumin was used. Furthermore, it was necessary to modify the procedure of Wasteneys and Borsook in order that it could be applied to experiments with insulin. Experiment 1. Albumin-Amorphous Pepsin.uTo 1.00 gin. of egg albumin in 35.0 cc. of water at pH 1.9, were added 75 rag. of amorphous pepsin (Parke, Davis and Company 1 : 10,000) aud 3 drops of chloroform. After standing at 37°C. for 70 hours, samples were removed for the determination of the total, the protein, and the non-protein nitrogen. The rest of the solution was adjusted to pH 4.2 with 1.6 cc. of normal sodium hydroxide and the material concentrated by distillation under reduced pressure to about 2.5 cc. The time of distillation was 2 hours. The temperature during concentration was not above 40°C., most of the material distilling at 37°C. After adding 0.2 cc. of a solution containing 44 nag. of amorphous pepsin and then 3 drops of chloroform, the mixture was set at 37°C. for 69 hours. Water was then added until the volume was the same as that before adjusting to pH 4. Immediately, samples of the mixture were removed and the total and nonprotein nitrogen estimated on these. The results of this experiment are shown in Table I .
From this experiment, it is evident that it is possible to demonstrate synthesis of plastein in a digest obtained from a small quantity of albumin. Accordingly, the work was continued, using similar quantities of insulin. solution of 1.00 gin. of amorphous insulin in 35.0 cc. of water at pH 1.8 was prepared. To this were added 75 rag. of amorphous pepsin and 4 drops of chloroform. After standing at 37°C. for 50 hours, the solution was removed from the incubator, since hydrolysis seemed almost complete. Five samples were immediately removed for biological assay and diluted in the manner previously described. The tests showed that more than 99 per cent of the potency had been destroyed. Other samples were removed from the digestion mixture and the total and the non-protein nitrogen estimated. The rest of the solution was adjusted to pH 4.0 with normal sodium hydroxide and concentrated under reduced pressure to 2.6 co. The temperature during distilla- tion was 23°C. 5 drops of amyl alcohol were added to inhibit frothing. The time of concentration was 4 hours. After the addition of 0.2 cc. of a solution containing 44 rag. of amorphous pepsin and 3 drops of chloroform, the mixture was set at 30°C. for 70 hours. Then it was diluted to 35.0 cc. and five samples were removed immediately for biological assay. These solutions were diluted in the usual manner to detect a recovery of 2 per cent of the potency. The tests showed no indication of physiological activity. Other samples of the mixture were removed for nitrogen determinations. The experimental results are indicated in Table II. Since the insulin-plastein obtained in the above experiment was physiologically inactive, it was thought that this might be due to the fact that hydrolysis had progressed too far. Accordingly, it was decided to attempt to recover the potency using a digest in which hydrolysis had been stopped when the physiological activity had just been destroyed and when only about 50 per cent of the protein had been digested. of amorphous pepsin were added and the solution incubated at 37°C. for 3 hours. Then samples were removed, diluted, and tested for physiological activity. These tests showed that more than 99 per cent of the potency had been destroyed. After removing 3.0 cc. for the total and the non-protein nitrogen determinations, the rest of the solution was adjusted to pH 7.0 with normal sodium hydroxide in order to minimize the possibility of further hydrolysis taking place in the dilute solution during the first stages of concentration. Attempts to concentrate this material by distillation under reduced pressure were not successful due to persistent frothing. The addition of amyl alcohol did not overcome this difficulty. Accordingly, the mixture was frozen with solid carbon dioxide and placed in vacuo over concentrated sulfuric acid. At the end of 8 hours, the material in the flask was dry. A small amount of water was added to the powder and the mixture adjusted to pH 4.0. After the addition of 0.2 cc. of a solution containing 44 nag. of amorphous pepsin, the volume was about 3 cc. 2 drops of chloroform were added and the mixture incubated at 37°C. for 110 hours. It was then diluted and five samples were immediately removed and assayed biologically, assuming a recovery of 2 per cent of the original potency. These tests showed no indication of the insulin-plastein possessing physiological activity. Samples of the mixture were also removed for nitrogen determinations. The values obtained in this experiment are given in Table III .
It seemed probable that the failure to obtain any physiological activity in the insulin-plastein synthesised in the above experiments might be due to the presence of foreign substances in the amorphous insulin and amorphous pepsin. The possibility of such impurities taking part in synthesis to form a physiologically inactive plastein, did not seem too remote for consideration. This difficulty could be overcome by the use of crystalline insulin and crystalline pepsin. However, since the synthetic action of crystalline pepsin on a protein digest had not previously been investigated, an experiment with egg album~n was first conducted. This experiment is reported below. hours, samples were removed for nitrogen determinations and the rest of the solution was adjusted to pH 4. The mixture was frozen with solid carbon dioxide and concentrated by sublimation in vacuo (in 4 hours) as in the former experiment. Then 0.35 cc. of a solution containing 13.6 mg. of crystalline pepsin and water sufficient to make a volume of 2.5 cc. were added and the mixture incubated at 37°C. for 113 hours. The mixture was then diluted and samples were removed for nitrogen determinations. The results of this experiment are given in Table IV. From the above experiment, it is evident that crystalline pepsin can be used to synthesise plastein from hydrolysed egg albumin. Accordingly, it was decided to carry out an experiment using crystalline insulin and crystalline pepsin.
Experiment 5. Crystalline Insulin-Crystalline Pepsln.--To 250 mg. of crystalline insulin in 8.6 co. of water at pH 1.9 was added 0.13 cc. of a solution containing 5.1 rag. of crystalline pepsin. This solution was incubated at 37°C. for 2 hours. Five samples were then removed for biological assay. These tests showed that more than 99 per cent of the potency had been destroyed. Other samples were removed to determine the total and non-protein nitrogen. The remaining digest was adjusted to pH 4.0, frozen with solid carbon dioxide, and set in vacuo over concentrated sulfuric acid for !9 hours. To the dry powder was added 0.075 cc. of a solution containing 2.9 rag. of crystalline pepsin and the volume was made up to 0.6 cc. The mixture was incubated at 37°C. for 83 hours. Then 8.0 cc. of water were added and five samples were immediately removed for biological assay. These samples were diluted to detect a recovery of 1 per cent of the original potency. The tests showed that the material was physiologically inactive. Samples were also removed to determine the total and non-protein nitrogen. The results are listed in Table V. Several attempts were made to crystallise the insulin-plastein, using methods which were suitable for crystallising insulin (2, 16) . No crystals were formed in these experiments. To confirm the results shown in Tables IV and V the experiments with albumin and with crystalline insulin were repeated, using crystalline pepsin prepared by Northrop.
Experiment 6. Albumin-Crystalline
Pepsin (Northrop) .--To 0.500 gm. of egg albumin in 16.7 co. of water, at pH 1.7, were added 0.8 co. of a solution containing 13 rag. of crystalline pepsin prepared by Northrop, and 3 drops of chloroform. After incubation at 37°C. for 47 hours, samples of the digest were removed to determine the total and the non-protein nitrogen. The remainder of the solution was adjusted to pH 4.2, frozen with solid carbon dioxide, and set in vacuo over concentrated sulfuric acid for 16 hours. At the end of this time, the material was dry. To this, 0.5 co. of a solution containing 8.2 nag. of crystalline pepsin (Northrop) was added. The volume was made up to 1.25 co. with water and 3 small drops of chloroform added. After incubation at 37°C. for 72 hours, the mixture was diluted and samples were immediately removed for the determination of the total and the non-protein nitrogen. The results of this experiment are shown in Table VI .
Experiment

Crystalline Insulin-Crystalline Pepsin (Northrop).--To
0.500 gm. of crystalline insulin dissolved in 16.7 cc. of water at pH 1.8 was added 0.8 cc. of a solution containing 13 rag. of crystalline pepsin (Northrop) . After incubation at 37°C. for 2 hours, five 0.1 cc. samples were removed for biological assay. These tests showed that more than 99 per cent of the activity had been destroyed. Other samples were removed to determine the total and the non-protein nitrogen. The rest of the solution was adjusted to pH 4.0 with normal sodium hydroxide, frozen in solid carbon dioxide, and set in vacuo over concentrated sulfuric acid for 16 hours. Then 0.5 cc. of a solution containing 8.2 mg. of crystalline pepsin (Northrop) and sufficient water to make a final volume of 1.7 cc. were added. After the addition of 2 small drops of chloroform, the mixture was set at 37°12. for 99 hours. Then it was diluted and samples were immediately removed for nitrogen determinations and for biological assay. The latter samples were further diluted as previously described and when tested to detect a recovery of 1 per cent of the original potency, showed no evidence of physiological activity. The nitrogen values are shown in Table VII . Further attempts were made in this experiment to crystallise the synthesised material, but no crystals were formed.
It was considered advisable to investigate the effect on the potency of insulin of certain conditions used in the previous experiments during the concentration and synthesis of the digest. If these conditions destroyed the activity of insulin, it did not seem reasonable to expect that the insulin-plastein would be physiologically active. These experiments are reported below.
Effect of Extreme
Cold on the Activity of Insulin.--Since sublimation of solutions frozen with solid carbon dioxide offered an excellent means of concentrating the protein digests preparatory to synthesis, it seemed advisable to investigate the effect of extreme cold on the potency of insulin. Two solutions were prepared: (a) 15 rag. of amorphous insulin dissolved in 5 cc. of water at pH 1.9; (b) 15 rag. of amorphous insulin dissolved in 4.0 cc. of denatured ethyl alcohol acidified with 1.0 cc. of 0.07 normal hydrochloric acid. These solutions were alternately frozen in solid carbon dioxide and melted. This process was repeated nine times, the total time in the carbon dioxide being 12 hours. The solutions were then suitably diluted and biologically assayed. These tests showed that no potency had been destroyed by this treatment.
Effect of Pepsin on Insulin at pH 4.0.--It is well known that the potency of insulin is destroyed by pepsin at pH 1.8, but the effect of the enzyme on the physiological activity at pH 4.0, that used during synthesis in these experiments, was problematic. Accordingly, experiments were conducted with insulin and pepsin at pH 4.0 at dilutions comparable with those used during hydrolysis and synthesis. These experiments were carried out in the following manner. 50 mg. of amorphous insulin were mixed with 3.7 nag. of amorphous pepsin in 0.2 cc. of rr/10,000 hydrochloric acid. After incubation at 37°C. for 50 hours, 25 cc. of water were added. The acidity was then pH 5.0. The mixture was diluted with isotonic saline, pH 8.0. A biological assay showed that there had been no appreciable loss of potency during the experiment. The work was repeated and the above results were confirmed.
The action of pepsin on insulin in more dilute solutions at pH 4.0 was next investigated. To 10 mg. of insulin dissolved in acid water at pH 2.5, 0.5 rag. of pepsin was added. The solution was then immediately adjusted to pH 4.2. The final volume was 4.7 cc. After incubation at 37°C. for 4 days, the solution was suitably diluted with isotonic saline, pH 8.0, and assayed biologically. These tests showed that not more than 10 per cent of the activity had been lost during the experiment.
Previous investigators have shown that when a suitable amount of trypsin is added to insulin, a physiologically inactive insulin-trypsin complex is formed immediately (17) . Since a similar adsorption phenomenon might occur in the present insulin-pepsin experiments, this possibility was investigated. Accordingly, 20 nag. of insulin were dissolved in 0.2 cc. of acid water at pH 2.0. To this were added 1.5 rag. of pepsin in 0.5 cc. of acid water, at pH 2.0. The solution was shaken and immediately suitably diluted with isotonic saline, pH 8.0. A biological assay showed no loss of potency.
DISCUSSION
From the results of Experiment 1, it is evident that synthesis of plastein from a peptic digest of albumin can be demonstrated with quantities of materials sufficiently small to permit a similar investigation of insulin. Further, the procedure employed was suitable for similar experiments with insulin. The synthesis of the albuminplastein was obtained by means of amorphous pepsin. In Experiments 4 and 6, an attempt was made to synthesise plastein from albumin digests by means of crystalline pepsin. From the results of these investigations, as shown in Tables IV and VI, it is evident that crystalline pepsin synthesises plastein from albumin digests equally as well as amorphous pepsin.
In Experiment 2, the synthetic action of amorphous pepsin on a peptic digest of amorphous insulin, was investigated. The results of this experiment are tabulated in Table II . They show that 55 per cent of the protein digest was converted into insulin-plastein. Five different samples of this synthesised material were prepared and tested for physiological activity. No potency, however, was detected in any of these tests. It was thought that the failure to recover any physiological activity might be due to the fact that digestion in this experiment had gone to completion, and that the possibility of recovering the activity would be greater if the hydrolysis was stopped when the potency had just disappeared. From previous experiments, it was known that this occurred when approximately 50 per cent of the protein was hydrolysed. Accordingly, in Experiment 3, amorphous insulin was digested until 52 per cent of the protein had been hydrolysed. A biological assay at this time, showed that more than 99 per cent of the activity had been destroyed. A small amount of insulin-plastein was synthesised from this digest, as is shown in Table  III . This material, however, when suitably diluted, showed no physiological activity. Since great difficulty was encountered during concentration by distillation under reduced pressure due to persistent frothing, it was found necessary to concentrate the material by other means. This was done by freezing the mixture with solid carbon dioxide and standing it in vacuo over concentrated sulfuric acid for a few hours until a dry powder was obtained. Since this method was also used in Experiments 4 and 6 with egg albumin, it is evident that it does not inhibit synthesis. It was also shown, in other experiments, that the extreme cold used to freeze the mixture does not destroy the physiological activity of insulin since solutions of insulin were alternately frozen with solid carbon dioxide and melted nine times without loss of potency. The success of this method of concentration justified its use in all subsequent work.
In view of the fact that Wasteneys and Borsook (18) found that all fractions of the hydrolysed digest contributed to the formation of plastein, it seemed probable that the impurities present in the amorphous insulin and the amorphous pepsin might have been responsible for the insulin-plastein in Experiments 2 and 3 being physiologically inactive. Since both insulin and pepsin are now available in crystalline form, it was decided to repeat the work using these substances and thus avoid this objection to the former insulin experiments. These experiments, Nos. 5 and 7, have been described, and the results obtained are shown in Tables V and VII. In both experiments, insulin-plastein was synthesised. This material, however, was physiologically inactive.
In the present investigation little work has been done on the insulinplastein; however, certain observations were made. The plastein was soluble in dilute acid and dilute alkali. It had an isoelectric point at approximately pH 5.0, and in this respect was similar to amorphous insulin. Attempts were made to crystallise the insulin-plastein obtained from digests of crystalline insulin but no crystals were formed by methods which were suitable for crystallising insulin.
In certain experiments, the tables show a decrease in the total nitrogen after synthesis. This is particularly evident in experiments in which concentration was effected by distillation under reduced pressure. This shortage in nitrogen cannot be attributed to removal of material in the distillate, since the nitrogen there was estimated and found to be negligible. Owing to frothing and bumping during the later stages of concentration, considerable material was deposited on the inside of the flask. In certain experiments, it was dissolved in normal sodium hydroxide and the nitrogen estimated. It was found to contain approximately the correct amount of nitrogen to account for the shortage. This material is, presumably, non-hydrolysed protein or synthesised plastein since subsequent dilution and washing with water failed to remove it. For this reason, the value for the plastein nitrogen in the previous experiments has been obtained by subtracting the non-protein nitrogen after incubation at pH 4.0 from the non-protein nitrogen after hydrolysis. All nitrogen determinations have been made in duplicate. Most of the values agreed within 1 per cent and none of them differed by more than 2 per cent. In some cases, duplicate samples of the digest were removed and a similar degree of accuracy was obtained.
The extent of synthesis obtained in the various experiments is summarised in Table VIII . The values given were determined, as in the experiments of Wasteneys and Borsook, from the ratio of the plastein nitrogen to the total nitrogen after synthesis. However, since hydrolysis in the different experiments was carried to widely different degrees, as is apparent from Table VIII , and since the amount of plastein synthesised is partly dependent upon the nonprotein nitrogen present, this method of estimation does not afford a true comparison of the insulin experiments with those of albumin. Therefore, it was thought that a better expression of the degree of synthesis would be obtained if the results were expressed as the ratio of the plastein nitrogen to the non-protein nitrogen before synthesis. This also avoids the use of the value determined for the total nitrogen, which, as has already been shown, is subject to a percentage error in certain experiments. The results calculated in this manner are also given in Table VIII . From Table VIII it is evident that the degree of synthesis obtained in the experiments with egg albumin is of the same order as that obtained by Wasteneys and Borsook. In Experiment 2, in which the amorphous insulin was completely hydrolysed, a slightly greater amount of plastein was obtained than in the albumin experiments. In other insulin experiments (Nos. 3, 5, and 7) a much smaller percentage of synthesis took place. This was to be expected since only about 50 per cent of the insulin protein had been hydrolysed.
The failure to obtain any physiological activity with the synthesised plastein in any of the insulin experiments, cannot be attributed to the small amount of plastein formed in certain experiments, since the dilutions used in the biological assay were always such that any significant increase in physiological activity during synthesis could be detected. Nor can it be ascribed to an inactive insulin-pepsin adsorption complex, since it was possible to mix insulin and pepsin in the same ratio as in the above experiments, and then recover the activity of the insulin quantitatively. Further, it could not have been due to any secondary reaction of the pepsin on the insulin-plastein at pH 4.0, since it was shown that insulin could be incubated for 4 days with pepsin at pH 4.0 without any appreciable loss of activity.
Since we were primarily concerned in the present investigation with attempts to obtain a synthesised physiologically active plastein from the products of a peptic digest of insulin, little work was done on the products of hydrolysis or on the undigested fraction of the protein. Such investigations might shed much information on the chemistry of insulin.
.Although insulin-plastein may bear a similarity to insulin protein, in respect to complexity, still, there must be some difference between these two proteins, since the former is physiologically inactive and cannot be crystallised by methods used for the crystallisation of insulin. The present work with pepsin suggests a similar investigation using trypsin. Although the conditions required to demonstrate synthesis with this enzyme are not so dearly defined, yet, in view of the close association of insulin and trypsin in the pancreas, more interesting results might be anticipated.
SUMM~.Ry 1. Synthesis of plastein from the products of peptic hydrolysis of small quantities of egg albumin can be demonstrated with amorphous or crystalline pepsin.
2. Synthesis of plastein from the products of peptic hydrolysis of amorphous or crystalline insulin can be demonstrated with amorphous or crystalline pepsin.
